Univest Securities is acting as the sole placement agent for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QLGN:
- Qualigen Therapeutics Board Experiences Key Changes
- Qualigen Therapeutics Announces Executive Shakeup and Board Revamp
- Qualigen Therapeutics appoints Kevin Richardson as Interim CEO and CFO
- Qualigen Therapeutics Granted Nasdaq Listing Extension
- Qualigen Therapeutics receives extension from Nasdaq hearings panel